𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A phase II study of prednimustine in acute non-lymphocytic leukemia, smouldering leukemia, and refractory anemia with excess blasts

✍ Scribed by D. R. Gandara; C. A. Ries; S. A. Schiff; C. B. George; J. P. Lewis; M. M. Koretz; S. K. Carter

Publisher
Springer
Year
1982
Tongue
English
Weight
333 KB
Volume
9
Category
Article
ISSN
0344-5704

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Treatment of refractory chronic lymphocy
Treatment of refractory chronic lymphocytic leukemia with prednimustine: A phase II study using strict response criteria
✍ David R. Gandara; Christopher B. George; Curt A. Ries; Maria M. Koretz; Jerry P. πŸ“‚ Article πŸ“… 1987 πŸ› Springer 🌐 English βš– 388 KB

Twenty-one patients with refractory chronic lymphocytic leukemia (CLL) were entered into this Northern California Oncology Group (NCOG) study of prednimustine, an ester of chlorambucil and prednisolone. All patients had active disease and were refractory to standard alkylating agent chemotherapy. Tr

Treatment of refractory acute myeloid le
Treatment of refractory acute myeloid leukemia with mAMSA and VP 16-213 in combination: Results of a clinical phase I/II study
✍ Wolfgang Hiddemann; Dieter Urbanitz; Peter Preusser; Wolf Achterrath; Thomas BΓΌc πŸ“‚ Article πŸ“… 1989 πŸ› John Wiley and Sons 🌐 English βš– 482 KB

Twenty patients with refractory AML were treated with mAMSA and VP 16-2 13 in combination to assess the toxicity and anti-leukemic activity of the two-drug regimen. Refractoriness was defined according to the response to induction therapy consisting of 6-thioguanine, cytosine arabinoside and daunoru

A phase II study of homoharringtonine fo
A phase II study of homoharringtonine for the treatment of children with refractory or recurrent acute myelogenous leukemia: A pediatric oncology group study
✍ Bell, Beverly A. ;Chang, Myron N. ;Weinstein, Howard J. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 106 KB

## Abstract ## Background Homoharringtonine (HHT) is a plant alkaloid that is derived from a Chinese evergreen tree. Its mechanism of action is thought to be by inhibition of protein, DNA, and RNA synthesis by inhibition of chain initiation. The treatment of acute myelogenous leukemia (AML) in chi